# PF-06651600 Taste Study.

> **NCT03916393** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-06651600 20 mg
- **OTHER:** Bitrex solution

## Key facts

- **NCT ID:** NCT03916393
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03916393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03916393, "PF-06651600 Taste Study.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03916393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*